logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
返回期刊详情
European Urology Oncology 封面图

European Urology Oncology

IF9.3
论文数1327
被引数4058
期刊论文 1327
发表时间
delete
Neoadjuvant Therapy in Patients with Upper Tract Urothelial Cancer: An Updated Systematic Review and Meta-analysis上尿路尿路上皮癌患者的新辅助治疗：一项更新的系统评价和Meta分析
deleteEuropean Urology Oncology
IF9.3
delete2026-10-26
delete0
PREAI
deleteFrancesco Di Bello; Andrea Gallioli; David D’Andrea; Ekaterina Laukhtina; Francesco Soria; Francesco Del Giudice; Aleksander Ślusarczyk; Giorgio Graps; Marco Moschini; Wojciech Krajewski; Andrea Mari; Simone Albisinni; Laura Mertens; Laura Mas Grillo; Giulio Avesani; André R. Belarmino; Jeremy Yuen-Chun Teoh; Joan Palou; Benjamin Pradere; Alberto Breda
delete分享
delete收藏
The Nature of Progression on Active Surveillance for Favorable-risk Gleason Grade Group 2 Prostate Cancer对低风险Gleason分级组2前列腺癌进行主动监测时进展的性质
deleteEuropean Urology Oncology
IF9.3
delete2026-10-23
delete0
PREAI
deleteKevin Shee; Jonathan J. Song; Janet E. Cowan; C.K. Cornelia Ding; James Nie; Grace Lee; Brendan L. Raizenne; Jeffry P. Simko; Bradley A. Stohr; Nancy Greenland; Deepika Sirohi; Lufan Wang; Carissa E. Chu; Meera Chappidi; Samuel L. Washington; Katsuto Shinohara; Hao G. Nguyen; Matthew R. Cooperberg; Peter R. Carroll
delete分享
delete收藏
High Radiographic Response Rates After Metastasis-directed Radiation Therapy in SMARCB1-deficient Renal Medullary CarcinomaSMARCB1缺陷型肾髓样癌经转移灶定向放疗后的高影像学缓解率
deleteEuropean Urology Oncology
IF9.3
delete2026-10-21
delete0
PREAI
deleteShlok Mohanty; Pavlos Msaouel; Chad Tang
delete分享
delete收藏
Clinical Outcomes of Bladder-sparing Management Versus Early Radical Cystectomy in cT1 Micropapillary Bladder Cancer: A Systematic Review and Meta-analysis保留膀胱管理与早期根治性膀胱切除术在cT1微乳头状膀胱癌中的临床结局比较：一项系统评价和Meta分析
deleteEuropean Urology Oncology
IF9.3
delete2026-10-20
delete0
PREAI
deleteSagar R. Patel; Mikael Rauf; Yimin Geng; David Hinojosa-Gonzalez; Joseph B. Black; Taeweon Lee; Amanda A. Myers; Charles Guo; Roger Li; Joshua J. Meeks; Piyush Agarwal; Stephen Williams; Omar Alhalabi; Andrea Necchi; Laura S. Mertens; Paolo Gontero; Neema Navai; Ashish M. Kamat
delete分享
delete收藏
Re: Alfonso Santangelo, Wooju Jeong, Caro Silvani, et al. Long-term Oncological Outcomes of Retzius-sparing Versus Anterior Robot-assisted Radical Prostatectomy: Post Hoc Analysis of a Randomized Cohort. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2026.07.012关于阿尔方索·桑蒂亚戈、乌珠·郑、卡罗·西尔瓦尼等人。保留Retzius间隙与经腹机器人辅助根治性前列腺切除术的长期肿瘤学结果比较：一项随机队列研究的后验分析。欧洲泌尿肿瘤学。待发表。https://doi.org/10.1016/j.euo.2026.07.012
deleteEuropean Urology Oncology
IF9.3
delete2026-10-16
delete0
PREAI
deleteDenis Seguier; Arnauld Villers; Jonathan Olivier
delete分享
delete收藏
Prostate Cancer Incidence and Disease Characteristics in Transgender Women Receiving Gender-affirming Hormone Therapy: A Systematic Review with Meta-analysistransgender女性接受性别肯定激素治疗后的前列腺癌发病率和疾病特征：一项系统综述与Meta分析
deleteEuropean Urology Oncology
IF9.3
delete2026-10-16
delete0
deleteOAAI
deleteKunind Oberoi; Isabella Trevaskis; Sadia Hassan; Kapil Sethi
delete分享
delete收藏
Machine Learning Models Combining [68Ga]Ga-PSMA-11 PET Radiomics and Clinical Features to Predict Overall Survival for Metastatic Castration-resistant Prostate Cancer Treated with [177Lu]Lu-PSMA Radioligand Therapy结合 [68Ga]Ga-PSMA-11 PET 放射组学和临床特征预测接受 [177Lu]Lu-PSMA 放射配体治疗转移性去势抵抗性前列腺癌患者总生存期的机器学习模型
deleteEuropean Urology Oncology
IF9.3
delete2026-10-15
delete0
PREAI
deleteLucas Edouard; Léa Papillon; Loïc Ferrer; Yann Godbert; Marie Meyer; Vincent Prega-Renaud; Céline Subreville; Nadège Anizan; Nicolas Benziane-Ouaritini; Olivier Gallinato; Mathilde Cabart; Diego Teyssonneau; Guilhem Roubaud; Thierry Colin; Paul Schwartz
delete分享
delete收藏
Re: Luc Delobel, Arnauld Villers, Denis Seguier, et al. Long-term Prediction of Metastatic Recurrence in Patients Candidate to Radical Prostatectomy Using MRI and Targeted Biopsy: Insights into Tumor Zonal Origin. Eur Urol Oncol. In press. http://dx.doi.org/10.1016/j.euo.2026.08.009关于 Luc Delobel、Arnauld Villers、Denis Seguier 等人：利用 MRI 和靶向活检预测接受根治性前列腺切除术患者长期转移性复发的可能性：对肿瘤区带起源的见解。欧洲泌尿肿瘤学杂志。待发表。http://dx.doi.org/10.1016/j.euo.2026.08.009
deleteEuropean Urology Oncology
IF9.3
delete2026-10-15
delete0
deleteOAAI
deleteMohamad Watfa; Jane K. Nguyen; Zeyad R. Schwen
delete分享
delete收藏
Metastasis-free Survival in High-risk Prostate Cancer: A Valid Surrogate, but Is it Transportable Across Strategies of Unequal Systemic Exposure?无转移生存期在高风险前列腺癌中的有效性：作为替代指标是否适用于不同系统性暴露策略？
deleteEuropean Urology Oncology
IF9.3
delete2026-10-06
delete0
PREAI
deleteMichael Baboudjian; Alessandro Uleri; Giuseppe Fallara; Alberto Martini; Guillaume Ploussard
delete分享
delete收藏
Efficacy and Safety of Olaparib plus Abiraterone Versus Placebo plus Abiraterone in the Non-BRCA Mutation Subgroup of Patients with Metastatic Castration-resistant Prostate Cancer in the PROpel Trial在PROpel试验中，奥拉帕利联合阿比特龙与安慰剂联合阿比特龙治疗转移性去势抵抗性前列腺癌非BRCA突变亚组患者的有效性与安全性比较
deleteEuropean Urology Oncology
IF9.3
delete2026-10-05
delete0
deleteOAAI
deleteNiven Mehra; Noel W. Clarke; Andrew J. Armstrong; Mototsugu Oya; Neal Shore; Giuseppe Procopio; João Daniel Guedes; Cagatay Arslan; Emma Brown; Jae Young Joung; Mikio Sugimoto; Young Deuk Choi; Daniel Castellano; Yüksel Ürün; Christian Hosius; David McGuinness; Arnold Degboe; Fred Saad
delete分享
delete收藏
Rethinking the 3-cm Rule: Toward Biology-guided Management of Sporadic Bilateral Multifocal Papillary Renal Cell Carcinoma重新审视3厘米规则：迈向生物导向的散发性双侧多灶性乳头状肾细胞癌的管理
deleteEuropean Urology Oncology
IF9.3
delete2026-09-29
delete0
PREAI
deleteSelcuk Erdem; Chiara Re; Umberto Capitanio
delete分享
delete收藏
Adjuvant Pembrolizumab in Clear Cell Renal Cell Carcinoma: Eligibility Is Only the Beginning帕博利珠单抗在透明细胞肾细胞癌中的辅助治疗：适用性仅是开端
deleteEuropean Urology Oncology
IF9.3
delete2026-09-26
delete0
PREAI
deleteFrancesco Rossi; Massimiliano Depalma; Bernardo Rocco; Riccardo Autorino
delete分享
delete收藏
Reply to Roberto M. Scarpa’s Letter to the Editor re: Paolo Gontero, Richard Perry, Daisy Bridge, et al. Unmet Treatment Need and Challenges Associated with Comparative Evidence Generation in BCG-unresponsive Non–muscle-invasive Bladder Cancer: An Expert Consensus. Eur Urol Oncol 2026;9(3):652–9回复罗伯托·M·斯卡帕致编辑的信：关于保罗·贡特罗、理查德·佩里、黛西·布里奇等人撰写的《BCG无应答性非肌层浸润性膀胱癌未满足的治疗需求及比较证据生成相关的挑战：一项专家共识》。欧洲泌尿肿瘤学2026；9(3)：652–9
deleteEuropean Urology Oncology
IF9.3
delete2026-09-26
delete0
PREAI
deletePaolo Gontero; Marek Babjuk
delete分享
delete收藏
Assessing Pathological Response to Neoadjuvant Therapy in Kidney Cancer: Quality over Quantity?评估肾癌新辅助治疗后的病理反应：质量重于数量？
deleteEuropean Urology Oncology
IF9.3
delete2026-09-23
delete0
PREAI
deleteJames O. Jones; J.C. Koen van der Mijn; Axel Bex; Grant D. Stewart
delete分享
delete收藏
TACTICAL1 Trial Protocol: Targeted Abdominal CT in Conjunction with Lung Cancer Screening to Identify Kidney Cancer and Other Abdominal Conditions: A Randomised Controlled Pilot StudyTACTICAL1试验方案：结合肺癌筛查进行靶向腹部CT以识别肾癌及其他腹部病变：一项随机对照试点研究
deleteEuropean Urology Oncology
IF9.3
delete2026-09-22
delete0
deleteOAAI
deleteSabrina H. Rossi; Jessica Kitt; Michelle Clark; Robert Bradley; Oliver Byass; Seonaidh Cotton; Tracy Holmes; Grigorios Kyriazis; Graeme MacLennan; Stewart Manning; Kerrie Massey; Rakesh Modi; Andrew Myatt; Jason Pawluk; Jonathan C.L. Rodrigues; Kanwal Tariq; Andrew Stephens; Tim Wood; Juliet A. Usher-Smith; Grant D. Stewart
delete分享
delete收藏
Quantity Improves Quality: Better Outcomes for Patients with Testicular Cancer Through Centralised Care: Recommendations from the European Association of Urology Guidelines Panel on Testicular Cancer数量提升质量：通过集中化管理改善睾丸癌患者预后：欧洲泌尿外科学会睾丸癌指南专家组建议
deleteEuropean Urology Oncology
IF9.3
delete2026-09-21
delete0
PREAI
deleteChristoph Oing; Hege Sagstuen Haugnes; Axel Heidenreich
delete分享
delete收藏
Triplet Therapy in Metastatic Clear Cell Renal Cell Carcinoma: Time to Abandon Empiric, Biomarker-unselected Intensification?三联疗法在转移性透明细胞肾细胞癌中的应用：是时候放弃基于经验、未依据生物标志物选择的治疗强化了吗？
deleteEuropean Urology Oncology
IF9.3
delete2026-09-21
delete0
PREAI
deleteJavier Molina-Cerrillo; Victoria Gómez Dos Santos; Teresa Alonso-Gordoa
delete分享
delete收藏
Risk-informed Stratification and Counseling for Adjuvant Pembrolizumab in Clear Cell Renal Cell Carcinoma基于风险的分层和咨询用于辅助培美曲塞治疗透明细胞肾细胞癌
deleteEuropean Urology Oncology
IF9.3
delete2026-09-21
delete0
PREAI
deleteJeffrey Y. Zhong; Hannah M. Garcia; Pedro C. Barata
delete分享
delete收藏
Integrated Urine and Plasma DNA Analysis for Molecular Staging of Upper Tract Urothelial Carcinoma整合尿液和血浆DNA分析以进行上尿路尿路上皮癌的分子分期
deleteEuropean Urology Oncology
IF9.3
delete2026-09-19
delete0
deleteOAAI
deleteMaximilian Pallauf; Stephan Bronimann; Stanley Rapiey; Ezra Baraban; Shoujie Chai; Daniel S. Fischer; Vincent T. Bicocca; Trevor G. Levin; David J. McConkey; Nirmish Singla
delete分享
delete收藏
Reply to Roberto Mario Scarpa’s Letter to the Editor re: Roberto Contieri, Marco Paciotti, Alessandro Uleri, et al. Second Transurethral Resection of Bladder Tumor Can Be Safely Omitted in Selected Patients with T1 Non–muscle-invasive Bladder Cancer: Results from the Prospective HuNIRe Trial. Eur Urol Oncol 2026;9:404–12回复罗伯托·马里奥·斯卡帕致编辑的信：罗伯托·孔特里、马尔科·帕西奥蒂、亚历山德罗·乌莱里等人的研究“对于T1期非肌层浸润性膀胱癌的特定患者，第二次经尿道膀胱肿瘤切除术可安全省略：HuNIRe前瞻性试验结果”。《欧洲泌尿肿瘤学》2026；9：404–412
deleteEuropean Urology Oncology
IF9.3
delete2026-09-16
delete0
PREAI
deleteRoberto Contieri; Rodolfo Hurle
delete分享
delete收藏